Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Prestwick3_000429

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 18 USDMF, 16 CEP/COS, 2 JDMF, 6 EU WC, 7 NDC API, 22 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

106 Drugs in Development

106 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1002 FDF Dossiers, 6 FDA Orange Book, 665 Europe, 37 Canada, 6 Australia, 6 South Africa, 282 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, TABLET;ORAL - EQ 70MG BASE;2,800 IU, TABLET;ORAL - EQ 70MG BASE;5,600 IU

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 11 Rochem International Inc, 19 SPI Pharma, 18 DKSH, 2 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 14 Kirsch Pharma, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 32 BASF, 1 Bioplus Life Sciences, 5 CD Formulation, 1 Clariant, 11 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 11 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 35 Roquette, 16 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

91 Fillers, Diluents & Binders, 54 Thickeners and Stabilizers, 53 Coating Systems & Additives, 40 Taste Masking, 38 Solubilizers, 38 Parenteral, 35 Direct Compression, 32 Granulation, 29 Topical, 28 Controlled & Modified Release, 24 Film Formers & Plasticizers, 23 Disintegrants & Superdisintegrants, 21 Chewable & Orodispersible Aids, 18 Lubricants & Glidants, 17 Rheology Modifiers, 15 Co-Processed Excipients, 13 Emulsifying Agents, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 8 API Stability Enhancers, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 26 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 254 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

91 APIs, 23 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 Health Canada Patents

5 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 1 JP, 9 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
31/10/2025	DISHMAN NETHERLANDS B.V.	Netherlands	DISHMAN NETHERLANDS B.V. Veenendaal NL	R1-CEP 2007-347 - Rev 00	Cholecalciferol concentrate (oily form), 2 000 000 IU/g in arachis oil	2014-07-18	Valid	Chemical and TSE		575
31/10/2025	DISHMAN NETHERLANDS B.V.	Netherlands	DISHMAN NETHERLANDS B.V. Veenendaal NL	R1-CEP 2005-098 - Rev 03	Cholecalciferol	2012-02-07	Withdrawn by Holder	Chemical and TSE	2023-07-20	72

Prestwick3_000429

Prestwick3_000429

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

52 API Suppliers

18 USDMF

16 CEP/COS

2 JDMF

6 EU WC

7 NDC API

22 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

106 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1002 FDF Dossiers

6 FDA Orange Book

665 Europe

37 Canada

6 Australia

6 South Africa

282 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

TABLET;ORAL - EQ 70MG BASE;2,800 IU

TABLET;ORAL - EQ 70MG BASE;5,600 IU

RELATED EXCIPIENT COMPANIES

2 EUROAPI

11 Rochem International Inc

19 SPI Pharma

18 DKSH

2 Pharm-RX Chemical

4 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

8 Nanjing Well Pharmaceutical

2 Pfanstiehl

14 Kirsch Pharma

4 ACG Worldwide

11 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

32 BASF

1 Bioplus Life Sciences

5 CD Formulation

1 Clariant

11 Corel Pharma Chem

5 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

2 Finar

11 Gangwal Chemicals

4 Ideal Cures

4 Ingredion Pharma Solutions

20 Kerry

3 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

19 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

2 Pharmatrans-Sanaq

11 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

35 Roquette

16 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

3 Silverline Chemicals

4 The Dow Chemical Company